GE Forms CAD Partnership with Deus Technologies

A strategic partnership to develop a new digital computer-aided detection (CAD) product for lung cancer has been announced by GE Medical Systems (Waukesha, WI, USA) and Deus Technologies, LLC (Rockville, MD, USA). As part of the agreement, GE will have exclusive distribution rights to the new CAD product, which will be used on GE's suite of digital radiography x-ray systems.

Currently, the only CAD product for early lung cancer detection is the RapidScreen RS-2000 of Deus, for use with analog x-ray systems. This system identifies regions of interest on chest images that may have features associated with solitary pulmonary nodules, an important indication for early-stage lung cancer. According to the American Cancer Society, only 15% of lung cancer is detected in stage 1A, the most treatable stage. With the development of a new digital product, the two companies believe that CAD capabilities will be better integrated into a doctor's workflow.

"We are excited to work with GE Medical Systems on this initiative,” explained Michael Yeh, Ph.D., CEO of Deus. "Technical advances like this are particularly important when you consider that more than 50% of all radiologic procedures performed in the United States are chest x-rays.”


Related Links:
GE Medical
Deus Technologies